Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 249

1.

Characterization of human immunodeficiency virus type 1 (HIV-1) containing mutations in the nucleocapsid protein at a putative HIV-1 protease cleavage site.

Thomas JA, Shulenin S, Coren LV, Bosche WJ, Gagliardi TD, Gorelick RJ, Oroszlan S.

Virology. 2006 Oct 25;354(2):261-70. Epub 2006 Aug 9.

2.

Characterization of the murine leukemia virus protease and its comparison with the human immunodeficiency virus type 1 protease.

Fehér A, Boross P, Sperka T, Miklóssy G, Kádas J, Bagossi P, Oroszlan S, Weber IT, Tözsér J.

J Gen Virol. 2006 May;87(Pt 5):1321-30.

PMID:
16603535
3.

Replication-dependent fitness recovery of Human immunodeficiency virus 1 harbouring mutations of Asn17 of the nucleocapsid protein.

Tözsér J, Shulenin S, Young MR, Briggs CJ, Oroszlan S.

J Gen Virol. 2006 Apr;87(Pt 4):961-5.

PMID:
16528046
4.

Narrow substrate specificity and sensitivity toward ligand-binding site mutations of human T-cell Leukemia virus type 1 protease.

Kádas J, Weber IT, Bagossi P, Miklóssy G, Boross P, Oroszlan S, Tözsér J.

J Biol Chem. 2004 Jun 25;279(26):27148-57. Epub 2004 Apr 20.

5.
6.

Expression of the murine leukemia virus protease in fusion with maltose-binding protein in Escherichia coli.

Fehér A, Boross P, Sperka T, Oroszlan S, Tözsér J.

Protein Expr Purif. 2004 May;35(1):62-8.

PMID:
15039067
7.

Proteolytic events of HIV-1 replication as targets for therapeutic intervention.

Tözsér J, Oroszlan S.

Curr Pharm Des. 2003;9(22):1803-15. Review.

PMID:
12871198
8.

Human immunodeficiency virus type 1 capsid protein is a substrate of the retroviral proteinase while integrase is resistant toward proteolysis.

Tözsér J, Shulenin S, Kádas J, Boross P, Bagossi P, Copeland TD, Nair BC, Sarngadharan MG, Oroszlan S.

Virology. 2003 May 25;310(1):16-23.

9.

Rhesus monkey simian immunodeficiency virus infection as a model for assessing the role of selenium in AIDS.

Xu XM, Carlson BA, Grimm TA, Kutza J, Berry MJ, Arreola R, Fields KH, Shanmugam I, Jeang KT, Oroszlan S, Combs GF Jr, Marx PA, Gladyshev VN, Clouse KA, Hatfield DL.

J Acquir Immune Defic Syndr. 2002 Dec 15;31(5):453-63.

PMID:
12473832
10.

Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases.

Tözsér J, Zahuczky G, Bagossi P, Louis JM, Copeland TD, Oroszlan S, Harrison RW, Weber IT.

Eur J Biochem. 2000 Oct;267(20):6287-95.

11.

Cloning of the bovine leukemia virus proteinase in Escherichia coli and comparison of its specificity to that of human T-cell leukemia virus proteinase.

Zahuczky G, Boross P, Bagossi P, Emri G, Copeland TD, Oroszlan S, Louis JM, Tözsér J.

Biochim Biophys Acta. 2000 Mar 16;1478(1):1-8.

PMID:
10719169
12.

Expression and characterization of human foamy virus proteinase.

Fenyöfalvi G, Bagossi P, Copeland TD, Oroszlan S, Boross P, Tözsér J.

FEBS Lett. 1999 Dec 3;462(3):397-401.

13.

Comparison of the effect of FK506 and cyclosporin A on virus production in H9 cells chronically and newly infected by HIV-1.

Briggs CJ, Ott DE, Coren LV, Oroszlan S, Tözsér J.

Arch Virol. 1999;144(11):2151-60.

PMID:
10603169
14.

Effect of serine and tyrosine phosphorylation on retroviral proteinase substrates.

Tözsér J, Bagossi P, Boross P, Louis JM, Majerova E, Oroszlan S, Copeland TD.

Eur J Biochem. 1999 Oct 1;265(1):423-9.

15.

Effect of substrate residues on the P2' preference of retroviral proteinases.

Boross P, Bagossi P, Copeland TD, Oroszlan S, Louis JM, Tözsér J.

Eur J Biochem. 1999 Sep;264(3):921-9.

16.

Transfer RNA modification status influences retroviral ribosomal frameshifting.

Carlson BA, Kwon SY, Chamorro M, Oroszlan S, Hatfield DL, Lee BJ.

Virology. 1999 Mar 1;255(1):2-8.

17.
18.

Comparison of the specificity of homo- and heterodimeric linked HIV-1 and HIV-2 proteinase dimers.

Bagossi P, Cheng YS, Oroszlan S, Tözsér J.

Protein Eng. 1998 Jun;11(6):439-45.

PMID:
9725622
19.

Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type 1 and simian immunodeficiency virus and to the p12Gag protein of Moloney murine leukemia virus.

Ott DE, Coren LV, Copeland TD, Kane BP, Johnson DG, Sowder RC 2nd, Yoshinaka Y, Oroszlan S, Arthur LO, Henderson LE.

J Virol. 1998 Apr;72(4):2962-8.

20.

Studies on the symmetry and sequence context dependence of the HIV-1 proteinase specificity.

Tözsér J, Bagossi P, Weber IT, Louis JM, Copeland TD, Oroszlan S.

J Biol Chem. 1997 Jul 4;272(27):16807-14.

21.

Protein composition and morphology of human foamy virus intracellular cores and extracellular particles.

Morozov VA, Copeland TD, Nagashima K, Gonda MA, Oroszlan S.

Virology. 1997 Feb 17;228(2):307-17.

22.

Activity of tethered human immunodeficiency virus 1 protease containing mutations in the flap region of one subunit.

Tözsér J, Yin FH, Cheng YS, Bagossi P, Weber IT, Harrison RW, Oroszlan S.

Eur J Biochem. 1997 Feb 15;244(1):235-41.

23.
24.

Activity of linked HIV-1 proteinase dimers containing mutations in the active site region.

Bagossi P, Cheng YS, Oroszlan S, Tözsér J.

Protein Eng. 1996 Nov;9(11):997-1003.

PMID:
8961352
25.

Comparative studies on the substrate specificity of avian myeloblastosis virus proteinase and lentiviral proteinases.

Tözsér J, Bagossi P, Weber IT, Copeland TD, Oroszlan S.

J Biol Chem. 1996 Mar 22;271(12):6781-8.

26.
27.

Binding of human prothymosin alpha to the leucine-motif/activation domains of HTLV-I Rex and HIV-1 Rev.

Kubota S, Adachi Y, Copeland TD, Oroszlan S.

Eur J Biochem. 1995 Oct 1;233(1):48-54.

28.

Intracellular transport of the murine leukemia virus during acute infection of NIH 3T3 cells: nuclear import of nucleocapsid protein and integrase.

Risco C, Menéndez-Arias L, Copeland TD, Pinto da Silva P, Oroszlan S.

J Cell Sci. 1995 Sep;108 ( Pt 9):3039-50.

29.

Genome organization of a biologically active molecular clone of the lymphoproliferative disease virus of turkeys.

Sarid R, Chajut A, Gak E, Kim Y, Hixson CV, Oroszlan S, Tronick SR, Gazit A, Yaniv A.

Virology. 1994 Nov 1;204(2):680-91.

PMID:
7941337
30.

Kinetic and modeling studies of subsites S4-S3' of Moloney murine leukemia virus protease.

Menéndez-Arias L, Weber IT, Soss J, Harrison RW, Gotte D, Oroszlan S.

J Biol Chem. 1994 Jun 17;269(24):16795-801.

32.
33.

The origin of human immunodeficiency virus type-1 rev gene. An evolutionary hypothesis.

Kubota S, Oroszlan S, Hatanaka M.

FEBS Lett. 1994 Jan 31;338(2):118-21. Review.

34.

The site of antiviral action of 3-nitrosobenzamide on the infectivity process of human immunodeficiency virus in human lymphocytes.

Rice WG, Schaeffer CA, Graham L, Bu M, McDougal JS, Orloff SL, Villinger F, Young M, Oroszlan S, Fesen MR, et al.

Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9721-4.

35.

Moloney murine leukemia virus protease: bacterial expression and characterization of the purified enzyme.

Menéndez-Arias L, Gotte D, Oroszlan S.

Virology. 1993 Oct;196(2):557-63.

PMID:
8372434
36.
37.
38.

Studies on the substrate specificity of the proteinase of equine infectious anemia virus using oligopeptide substrates.

Tözsér J, Friedman D, Weber IT, Bláha I, Oroszlan S.

Biochemistry. 1993 Apr 6;32(13):3347-53.

PMID:
8384879
39.
40.

Purification and characterization of the mouse mammary tumor virus protease expressed in Escherichia coli.

Menéndez-Arias L, Young M, Oroszlan S.

J Biol Chem. 1992 Nov 25;267(33):24134-9.

41.

Phosphorylation of the Rex protein of human T-cell leukemia virus type I.

Adachi Y, Copeland TD, Takahashi C, Nosaka T, Ahmed A, Oroszlan S, Hatanaka M.

J Biol Chem. 1992 Oct 25;267(30):21977-81.

42.

Solid phase synthesis of the proteinase of bovine leukemia virus. Comparison of its specificity to that of HIV-2 proteinase.

Bláha I, Tözsér J, Kim Y, Copeland TD, Oroszlan S.

FEBS Lett. 1992 Sep 14;309(3):389-93.

43.

Purification of immature cores of mouse mammary tumor virus and immunolocalization of protein domains.

Menéndez-Arias L, Risco C, Pinto da Silva P, Oroszlan S.

J Virol. 1992 Sep;66(9):5615-20.

45.

Kinetic and modeling studies of S3-S3' subsites of HIV proteinases.

Tözsér J, Weber IT, Gustchina A, Bláha I, Copeland TD, Louis JM, Oroszlan S.

Biochemistry. 1992 May 26;31(20):4793-800.

PMID:
1591240
46.

Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M.

Nair BC, DeVico AL, Nakamura S, Copeland TD, Chen Y, Patel A, O'Neil T, Oroszlan S, Gallo RC, Sarngadharan MG.

Science. 1992 Mar 13;255(5050):1430-2.

PMID:
1542792
47.

Translational suppression in retroviral gene expression.

Hatfield DL, Levin JG, Rein A, Oroszlan S.

Adv Virus Res. 1992;41:193-239. Review. No abstract available.

PMID:
1575083
48.

Synthesis of homologous peptides using fragment condensation: analogs of an HIV proteinase substrate.

Bláha I, Nemec J, Tözsér J, Oroszlan S.

Int J Pept Protein Res. 1991 Nov;38(5):453-8.

PMID:
1802863
49.

HIV-1 proteinase is required for synthesis of pro-viral DNA.

Baboonian C, Dalgleish A, Bountiff L, Gross J, Oroszlan S, Rickett G, Smith-Burchnell C, Troke P, Merson J.

Biochem Biophys Res Commun. 1991 Aug 30;179(1):17-24. Erratum in: Biochem Biophys Res Commun 1992 Sep 16;187(2):1200.

PMID:
1652947
50.

In situ processing of a retroviral nucleocapsid protein by the viral proteinase.

Roberts MM, Copeland TD, Oroszlan S.

Protein Eng. 1991 Aug;4(6):695-700.

PMID:
1658777

Supplemental Content

Loading ...
Support Center